STOCK TITAN

[SCHEDULE 13G/A] TALPHERA, INC. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Rosalind Advisors and affiliates have filed an amended Schedule 13G reporting a sizable passive stake in Talphera, Inc. common shares. Rosalind Advisors Inc., Rosalind Master Fund L.P., and portfolio managers Steven Salamon and Gilad Aharon report beneficial ownership of 13,150,954 Talphera common shares, representing 9.9% of the class based on 46,609,618 shares outstanding as of November 5, 2025.

The position consists of 3,579,273 common shares plus additional shares issuable from warrants and pre‑funded warrants, some of which are subject to a 9.99% ownership blocker. The reporting persons certify the holdings are in the ordinary course of business and not for the purpose of influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 46,609,618 ordinary shares of the Issuers common stock outstanding as of November 5, 2025, based on the 10Q Filing of November 12, 2025. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 3,579,273 shares of Common Stock 5,074,285 shares of Common Stock issuable upon exercise of warrants 4,497,396 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,579,273 shares of Common Stock 5,074,285 shares of Common Stock issuable upon exercise of warrants 4,497,396 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,579,273 shares of Common Stock 5,074,285 shares of Common Stock issuable upon exercise of warrants 4,497,396 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,579,273 shares of Common Stock 5,074,285 shares of Common Stock issuable upon exercise of warrants 4,497,396 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:02/11/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:02/11/2026
Aharon Gil
Signature:Aharon Gil
Name/Title:Aharon Gil
Date:02/11/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:02/11/2026
Talphera Inc

NASDAQ:TLPH

TLPH Rankings

TLPH Latest News

TLPH Latest SEC Filings

TLPH Stock Data

37.88M
29.97M
2.39%
30.1%
2.15%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SAN MATEO